SC
Stephens Consulting’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $330K | Sell |
1,778
-45
| -2% | -$8.35K | 0.08% | 78 |
|
|
2025
Q1 | $382K | Sell |
1,823
-638
| -26% | -$134K | 0.1% | 65 |
|
|
2024
Q4 | $437K | Buy |
2,461
+723
| +42% | +$128K | 0.11% | 63 |
|
|
2024
Q3 | $343K | Sell |
1,738
-12
| -0.7% | -$2.37K | 0.09% | 72 |
|
|
2024
Q2 | $300K | Buy |
1,750
+24
| +1% | +$4.12K | 0.09% | 72 |
|
|
2024
Q1 | $314K | Sell |
1,726
-18
| -1% | -$3.28K | 0.1% | 68 |
|
|
2023
Q4 | $270K | Sell |
1,744
-32
| -2% | -$4.96K | 0.09% | 70 |
|
|
2023
Q3 | $265K | Sell |
1,776
-49
| -3% | -$7.3K | 0.11% | 63 |
|
|
2023
Q2 | $246K | Sell |
1,825
-18
| -1% | -$2.43K | 0.1% | 67 |
|
|
2023
Q1 | $294K | Sell |
1,843
-130
| -7% | -$20.7K | 0.18% | 61 |
|
|
2022
Q4 | $319K | Sell |
1,973
-122
| -6% | -$19.7K | 0.21% | 57 |
|
|
2022
Q3 | $281K | Sell |
2,095
-126
| -6% | -$16.9K | 0.25% | 56 |
|
|
2022
Q2 | $340K | Sell |
2,221
-24
| -1% | -$3.68K | 0.28% | 44 |
|
|
2022
Q1 | $364K | Sell |
2,245
-272
| -11% | -$44.1K | 0.3% | 49 |
|
|
2021
Q4 | $341K | Buy |
+2,517
| New | +$341K | 0.28% | 57 |
|